US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 32.200
  • +1.250+4.04%
Close Dec 20 16:00 ET
  • 32.200
  • 0.0000.00%
Post 19:50 ET
5.01BMarket Cap-322.00P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-114.58%-12.21M
113.18%5.54M
86.30%-8.21M
82.17%-31.41M
44.66%-13.21M
342.66%83.7M
14.48%-42.01M
12.79%-59.9M
40.41%-176.17M
72.53%-23.87M
Net income from continuing operations
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.52%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
Depreciation and amortization
-49.21%64K
-15.29%72K
-32.23%82K
-17.86%423K
-27.78%91K
-2.33%126K
-35.11%85K
-6.20%121K
4.25%515K
-5.26%126K
Other non cash items
31.39%1.04M
-10.75%1.2M
0.00%1.01M
0.25%4.45M
19.80%1.31M
-53.17%790K
93.08%1.34M
4.66%1.01M
85.28%4.44M
83.58%1.1M
Change In working capital
20.65%-31.83M
-30.44%-10.67M
78.58%-6.07M
-5,040.19%-84.66M
-147.33%-8.05M
-447.47%-40.11M
2.85%-8.18M
-871.66%-28.32M
86.52%-1.65M
294.33%17.01M
-Change in receivables
-47.09%-32.12M
-110.20%-18.63M
-61.07%-13.89M
-3,778.40%-51.09M
---11.77M
-24,913.64%-21.84M
-1,188.57%-8.86M
-1,870.64%-8.62M
200.00%1.39M
--0
-Change in inventory
-0.16%-2.54M
-29.82%-2.56M
-37.17%-36.93M
---36.94M
---5.51M
---2.54M
---1.97M
---26.92M
--0
--0
-Change in payables and accrued expense
154.25%11.67M
-3.44%8.96M
308.01%40.22M
101.74%192K
-84.39%2.56M
-253.69%-21.51M
182.95%9.28M
196.93%9.86M
-168.85%-11.01M
321.07%16.43M
-Change in other current assets
-2,339.18%-25.59M
115.69%1.05M
156.81%1.49M
-134.60%-2.83M
2,122.42%7.53M
-394.81%-1.05M
-616.83%-6.69M
-138.81%-2.62M
196.16%8.18M
127.06%339K
-Change in other current liabilities
-1,388.89%-1.39M
-87.27%14K
9,280.77%2.44M
645.45%300K
-80.21%56K
109.97%108K
-84.24%110K
-44.68%26K
99.70%-55K
102.49%283K
-Change in other working capital
170.28%18.14M
1,410.53%498K
1,684.21%602K
3,857.24%5.71M
-2,336.84%-926K
17,765.79%6.71M
0.00%-38K
0.00%-38K
0.00%-152K
0.00%-38K
Cash from discontinued investing activities
Operating cash flow
-114.58%-12.21M
113.18%5.54M
86.30%-8.21M
82.17%-31.41M
44.66%-13.21M
342.66%83.7M
14.48%-42.01M
12.79%-59.9M
40.41%-176.17M
72.53%-23.87M
Investing cash flow
Cash flow from continuing investing activities
69.12%-9.33M
-94.21%1.77M
-50.05%-9.26M
-153.09%-50.65M
-375.09%-44.76M
-911.00%-30.23M
193.87%30.5M
85.88%-6.17M
-5,928.01%-20.01M
394.80%16.27M
Net PPE purchase and sale
----
----
----
--0
--0
----
----
----
96.51%-14K
96.25%-3K
Net investment purchase and sale
69.20%-9.31M
-94.21%1.77M
-50.05%-9.26M
-153.27%-50.65M
-375.04%-44.76M
-912.36%-30.23M
193.87%30.5M
85.87%-6.17M
-29,084.06%-20M
383.14%16.27M
Cash from discontinued investing activities
Investing cash flow
69.12%-9.33M
-94.21%1.77M
-50.05%-9.26M
-153.09%-50.65M
-375.09%-44.76M
-911.00%-30.23M
193.87%30.5M
85.88%-6.17M
-5,928.01%-20.01M
394.80%16.27M
Financing cash flow
Cash flow from continuing financing activities
31,836.82%134.45M
-99.71%135K
-99.96%10K
18,694.63%72.71M
-102.04%-1K
53.09%421K
34,749.63%47.05M
3,069.18%25.24M
-100.94%-391K
-99.91%49K
Net issuance payments of debt
--137.26M
----
----
2,664.10%25M
--0
--0
--0
2,664.10%25M
-102.44%-975K
--0
Net common stock issuance
-215,000.00%-2.15M
----
----
--46.3M
---1K
--1K
----
----
--0
--0
Proceeds from stock option exercised by employees
-52.62%199K
-82.02%135K
-97.25%10K
162.67%1.53M
--0
52.73%420K
456.30%751K
190.40%363K
170.37%584K
--49K
Net other financing activities
----
----
----
---125K
--0
----
----
---125K
----
----
Cash from discontinued financing activities
Financing cash flow
31,836.82%134.45M
-99.71%135K
-99.96%10K
18,694.63%72.71M
-102.04%-1K
53.09%421K
34,749.63%47.05M
3,069.18%25.24M
-100.94%-391K
-99.91%49K
Net cash flow
Beginning cash position
-14.33%84.2M
22.35%76.77M
-9.04%94.22M
-65.49%103.58M
36.94%152.18M
-33.74%98.29M
-66.44%62.75M
-65.49%103.58M
-45.89%300.15M
-66.10%111.13M
Current changes in cash
109.51%112.92M
-79.08%7.44M
57.26%-17.45M
95.24%-9.36M
-667.56%-57.97M
244.84%53.9M
192.08%35.54M
63.93%-40.83M
22.77%-196.57M
72.66%-7.55M
End cash Position
29.53%197.12M
-14.33%84.2M
22.35%76.77M
-9.04%94.22M
-9.04%94.22M
36.94%152.18M
-33.74%98.29M
-66.44%62.75M
-65.49%103.58M
-65.49%103.58M
Free cash flow
-114.61%-12.23M
113.18%5.54M
86.30%-8.21M
82.17%-31.41M
44.67%-13.21M
342.63%83.7M
14.48%-42.01M
12.80%-59.9M
40.49%-176.18M
72.56%-23.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -114.58%-12.21M113.18%5.54M86.30%-8.21M82.17%-31.41M44.66%-13.21M342.66%83.7M14.48%-42.01M12.79%-59.9M40.41%-176.17M72.53%-23.87M
Net income from continuing operations -96.59%3.88M114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.52%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M
Depreciation and amortization -49.21%64K-15.29%72K-32.23%82K-17.86%423K-27.78%91K-2.33%126K-35.11%85K-6.20%121K4.25%515K-5.26%126K
Other non cash items 31.39%1.04M-10.75%1.2M0.00%1.01M0.25%4.45M19.80%1.31M-53.17%790K93.08%1.34M4.66%1.01M85.28%4.44M83.58%1.1M
Change In working capital 20.65%-31.83M-30.44%-10.67M78.58%-6.07M-5,040.19%-84.66M-147.33%-8.05M-447.47%-40.11M2.85%-8.18M-871.66%-28.32M86.52%-1.65M294.33%17.01M
-Change in receivables -47.09%-32.12M-110.20%-18.63M-61.07%-13.89M-3,778.40%-51.09M---11.77M-24,913.64%-21.84M-1,188.57%-8.86M-1,870.64%-8.62M200.00%1.39M--0
-Change in inventory -0.16%-2.54M-29.82%-2.56M-37.17%-36.93M---36.94M---5.51M---2.54M---1.97M---26.92M--0--0
-Change in payables and accrued expense 154.25%11.67M-3.44%8.96M308.01%40.22M101.74%192K-84.39%2.56M-253.69%-21.51M182.95%9.28M196.93%9.86M-168.85%-11.01M321.07%16.43M
-Change in other current assets -2,339.18%-25.59M115.69%1.05M156.81%1.49M-134.60%-2.83M2,122.42%7.53M-394.81%-1.05M-616.83%-6.69M-138.81%-2.62M196.16%8.18M127.06%339K
-Change in other current liabilities -1,388.89%-1.39M-87.27%14K9,280.77%2.44M645.45%300K-80.21%56K109.97%108K-84.24%110K-44.68%26K99.70%-55K102.49%283K
-Change in other working capital 170.28%18.14M1,410.53%498K1,684.21%602K3,857.24%5.71M-2,336.84%-926K17,765.79%6.71M0.00%-38K0.00%-38K0.00%-152K0.00%-38K
Cash from discontinued investing activities
Operating cash flow -114.58%-12.21M113.18%5.54M86.30%-8.21M82.17%-31.41M44.66%-13.21M342.66%83.7M14.48%-42.01M12.79%-59.9M40.41%-176.17M72.53%-23.87M
Investing cash flow
Cash flow from continuing investing activities 69.12%-9.33M-94.21%1.77M-50.05%-9.26M-153.09%-50.65M-375.09%-44.76M-911.00%-30.23M193.87%30.5M85.88%-6.17M-5,928.01%-20.01M394.80%16.27M
Net PPE purchase and sale --------------0--0------------96.51%-14K96.25%-3K
Net investment purchase and sale 69.20%-9.31M-94.21%1.77M-50.05%-9.26M-153.27%-50.65M-375.04%-44.76M-912.36%-30.23M193.87%30.5M85.87%-6.17M-29,084.06%-20M383.14%16.27M
Cash from discontinued investing activities
Investing cash flow 69.12%-9.33M-94.21%1.77M-50.05%-9.26M-153.09%-50.65M-375.09%-44.76M-911.00%-30.23M193.87%30.5M85.88%-6.17M-5,928.01%-20.01M394.80%16.27M
Financing cash flow
Cash flow from continuing financing activities 31,836.82%134.45M-99.71%135K-99.96%10K18,694.63%72.71M-102.04%-1K53.09%421K34,749.63%47.05M3,069.18%25.24M-100.94%-391K-99.91%49K
Net issuance payments of debt --137.26M--------2,664.10%25M--0--0--02,664.10%25M-102.44%-975K--0
Net common stock issuance -215,000.00%-2.15M----------46.3M---1K--1K----------0--0
Proceeds from stock option exercised by employees -52.62%199K-82.02%135K-97.25%10K162.67%1.53M--052.73%420K456.30%751K190.40%363K170.37%584K--49K
Net other financing activities ---------------125K--0-----------125K--------
Cash from discontinued financing activities
Financing cash flow 31,836.82%134.45M-99.71%135K-99.96%10K18,694.63%72.71M-102.04%-1K53.09%421K34,749.63%47.05M3,069.18%25.24M-100.94%-391K-99.91%49K
Net cash flow
Beginning cash position -14.33%84.2M22.35%76.77M-9.04%94.22M-65.49%103.58M36.94%152.18M-33.74%98.29M-66.44%62.75M-65.49%103.58M-45.89%300.15M-66.10%111.13M
Current changes in cash 109.51%112.92M-79.08%7.44M57.26%-17.45M95.24%-9.36M-667.56%-57.97M244.84%53.9M192.08%35.54M63.93%-40.83M22.77%-196.57M72.66%-7.55M
End cash Position 29.53%197.12M-14.33%84.2M22.35%76.77M-9.04%94.22M-9.04%94.22M36.94%152.18M-33.74%98.29M-66.44%62.75M-65.49%103.58M-65.49%103.58M
Free cash flow -114.61%-12.23M113.18%5.54M86.30%-8.21M82.17%-31.41M44.67%-13.21M342.63%83.7M14.48%-42.01M12.80%-59.9M40.49%-176.18M72.56%-23.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List